1. Home
  2. ASH vs WGS Comparison

ASH vs WGS Comparison

Compare ASH & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$57.93

Market Cap

2.4B

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$69.62

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
WGS
Founded
1924
2017
Country
United States
United States
Employees
N/A
1300
Industry
Specialty Chemicals
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ASH
WGS
Price
$57.93
$69.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$65.57
$130.71
AVG Volume (30 Days)
568.1K
636.2K
Earning Date
04-28-2026
05-04-2026
Dividend Yield
2.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,824,000,000.00
N/A
Revenue This Year
$2.58
$29.98
Revenue Next Year
$4.28
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$46.30
$55.17
52 Week High
$65.65
$170.87

Technical Indicators

Market Signals
Indicator
ASH
WGS
Relative Strength Index (RSI) 58.84 50.72
Support Level $47.40 $68.55
Resistance Level $65.25 $95.75
Average True Range (ATR) 1.56 4.23
MACD 0.61 1.45
Stochastic Oscillator 72.37 81.62

Price Performance

Historical Comparison
ASH
WGS

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: